IWP iShares Russell Mid-Cap Growth ETF

Expense Ratio
0.23%
Dividend
0.36%
Previous close
$129.19
Est. 12 months change
+27.24%
Projected Price
$164.38

Profitability Metrics

Return on Equity (ROE)
29.41%
Return on Assets (ROA)
7.30%
Return on Invested Capital (ROIC)
25.97%
Weighted Average Cost of Capital (WACC)
10.36%
ROIC - WACC
15.61%
Updated : 2026-04-04 07:50 ET

Valuation Metrics

P/E Ratio
29.29
Forward P/E
22.89
PEG Ratio
1.86
Debt Current Ratio
2.14

Growth & Cash Flow

Gross Margin
49.28%
Operating Margin
12.05%
FCF Margin
17.66%
TTM Revenue Growth
25.78%
Projected 12M EPS Growth
27.98%

Price Change

Price % from 50 SMA
-3.39%
Price % from 200 SMA
-6.82%
6 Months
-9.95%
1 Year
7.15%
2 Years
15.32%
The above metrics represent weighted averages, calculated using each stock's individual value weighted by its proportion of ETF holdings.

Top 10 Holdings

Stock TickerWeight
HWM3.35%
VRT3.34%
HLT2.54%
RCL2.49%
PWR2.29%
NET2.29%
COR2.13%
TRGP1.97%
VST1.87%
MPWR1.74%

ETF Analysis

Fund Overview

iShares Russell Mid-Cap Growth ETF (IWP) currently reports 276 stock positions (subject to change), placing it in the broadly diversified range by holdings breadth. The top line-up is HWM (3.35%), VRT (3.34%), HLT (2.54%), with HWM as the largest single weight at 3.35%. Together, the top three holdings account for 9.23%, which indicates that performance drivers are distributed more evenly across the broader basket. This architecture allows the fund to express a clear investment thesis at the top while relying on the broader basket to manage idiosyncratic volatility.

Profitability & Capital Efficiency

From a capital efficiency perspective, ROIC is 25.97%, WACC is 10.36%, and the economic spread is 15.61%. On balance, holdings generate meaningful returns above their cost of capital, a hallmark of competitively advantaged businesses. Supporting metrics show ROE at 29.41% and ROA at 7.30%, a combination that helps frame whether profitability strength is broad enough to hold through different market conditions. Taken together, the return profile suggests a portfolio with credible compounding capacity if current operating execution persists.

Valuation

Valuation currently screens at trailing P/E of 29.29, forward P/E of 22.89, PEG of 1.86. Trailing and forward multiples are somewhat apart, indicating the market is pricing measured earnings growth without aggressive expansion assumptions. Growth-adjusted valuation is in a reasonable range, with the multiple broadly in line with expected earnings expansion. At 2.14, the aggregate current ratio indicates adequate but not exceptional balance sheet coverage. The valuation profile here is neither obviously cheap nor dramatically expensive — a setup where the return case is built more on earnings delivery than on re-rating potential.

Margins & Cash Generation

On the margin front: gross margin sits at 49.28%, operating margin at 12.05%, and free cash flow margin at 17.66%. At this level, the portfolio reflects reasonable cost discipline and adequate pricing leverage at the production layer. The operating margin reading is below average, pointing to businesses where scaling costs remain a challenge. Strong free cash flow margins point to businesses with meaningful financial flexibility and limited dependence on external capital. The margin stack is not uniformly strong, which means the portfolio's earnings resilience under adverse conditions is less certain.

Growth & Forward Outlook

On the forward picture: TTM revenue growth of 25.78% reflecting robust top-line expansion across the underlying holdings. Consensus EPS estimates point to 28.0% earnings growth over the next 12 months — a compelling near-term earnings catalyst that, if delivered, changes the valuation conversation materially. Analyst price targets suggest street expectations imply a constructive but measured return profile on a 12-month view. Revenue growth is grounded in reported results; price targets are forward projections that embed assumptions about multiple expansion, earnings delivery, and macro conditions. The key risk in both directions is whether the underlying businesses can maintain their operating trajectory as macro and sector conditions evolve. The estimated 12-month price change is a weighted composite of analyst price target estimates adjusted by each holding's ETF weight, sourced from publicly available data, and should not be interpreted as a reliable prediction of future performance.

Conclusion

Strong Buy

Across the metrics reviewed, the evidence is consistently constructive — quality, growth, and valuation are pulling in the same direction.

These findings are based solely on the metrics presented and do not constitute an investment recommendation. Always perform your own due diligence before committing capital.